Prescription medications, such as stronger antihistamines or topical steroids, might be prescribed by a healthcare professional
GLP-1 for Alcohol Addiction: Whats Coming Down the Pike SMART-AUD (NCT05520775) a 300-participant, twenty-four-week Phase 2b semaglutide trialfinishes data collection in Q4 2025 and will feed an FDA Fast-Track petition if endpoints hit
Clinical data from the past few years suggests that without proper resistance training, a significant percentage of weight lost on GLP-1 medications can come from lean muscle tissue
The MHRA has issued warnings about the risks of obtaining unlicensed injectable peptides including GLP-1 receptor agonists from unregulated online sources, citing concerns about uncertain purity and potency, absence of validated stability data, risk of microbial contamination in preparations not manufactured under Good Manufacturing Practice (GMP) conditions, and the potential for mislabelling or adulteration
Large-scale clinical trials of tirzepatide show that itching and pruritus occur infrequentlygenerally affecting less than 5% of treatment participants in most studies
2023;40:e15048